["[Tab] Consolidated Balance Sheets from AbbVie Inc.\n\n[Time]: December 31, 2023 [SEP]\n[row 0]: Current assets [SEP]\n[row 1]: Cash and equivalents | $12,814 [SEP] \n[row 2]: Short-term investments | $2 [SEP] \n[row 3]: Accounts receivable, net | $11,155 [SEP] \n[row 4]: Inventories | $4,099 [SEP] \n[row 5]: Prepaid expenses and other | $4,932 [SEP] \n[row 6]: Total current assets | $33,002 [SEP] \n[row 7]: Investments | $304 [SEP] \n[row 8]: Property and equipment, net | $4,989 [SEP] \n[row 9]: Intangible assets, net | $55,610 [SEP] \n[row 10]: Goodwill | $32,293 [SEP] \n[row 11]: Other assets | $8,513 [SEP] \n[row 12]: Total assets | $134,711 [SEP] \n[row 13]: Current liabilities [SEP] \n[row 14]: Current portion of long-term debt and finance lease obligations | $7,191 [SEP] \n[row 15]: Accounts payable and accrued liabilities | $30,650 [SEP] \n[row 16]: Total current liabilities | $37,841 [SEP] \n[row 17]: Long-term debt and finance lease obligations | $52,194 [SEP] \n[row 18]: Deferred income taxes | $1,952 [SEP] \n[row 19]: Other long-term liabilities | $32,327 [SEP] \n[row 20]: Commitments and contingencies | [SEP]\n[row 21]: Stockholders\u2019 equity [SEP] \n[row 22]: Common stock | $18 [SEP] \n[row 23]: Common stock held in treasury | $(6,533) [SEP] \n[row 24]: Additional paid-in capital | $20,180 [SEP] \n[row 25]: Retained earnings (accumulated deficit) | $(1,000) [SEP] \n[row 26]: Accumulated other comprehensive loss | $(2,305) [SEP] \n[row 27]: Total stockholders\u2019 equity | $10,360 [SEP] \n[row 28]: Noncontrolling interest | $37 [SEP] \n[row 29]: Total equity | $10,397 [SEP] \n[row 30]: Total liabilities and equity | $134,711 [SEP] \n\n[Time]: December 31, 2022 [SEP]\n[row 0]: Current assets [SEP]\n[row 1]: Cash and equivalents | $9,201 [SEP] \n[row 2]: Short-term investments | $28 [SEP] \n[row 3]: Accounts receivable, net | $11,254 [SEP] \n[row 4]: Inventories | $3,579 [SEP] \n[row 5]: Prepaid expenses and other | $4,401 [SEP] \n[row 6]: Total current assets | $28,463 [SEP] \n[row 7]: Investments | $241 [SEP] \n[row 8]: Property and equipment, net | $4,935 [SEP] \n[row 9]: Intangible assets, net | $67,439 [SEP] \n[row 10]: Goodwill | $32,156 [SEP] \n[row 11]: Other assets | $5,571 [SEP] \n[row 12]: Total assets | $138,805 [SEP] \n[row 13]: Short-term borrowings | $1 [SEP] \n[row 14]: Current portion of long-term debt and finance lease obligations | $4,135 [SEP] \n[row 15]: Accounts payable and accrued liabilities | $25,402 [SEP] \n[row 16]: Total current liabilities | $29,538 [SEP] \n[row 17]: Long-term debt and finance lease obligations | $59,135 [SEP] \n[row 18]: Deferred income taxes | $2,190 [SEP] \n[row 19]: Other long-term liabilities | $30,655 [SEP] \n[row 20]: Commitments and contingencies | [SEP]\n[row 21]: Stockholders\u2019 equity [SEP] \n[row 22]: Common stock | $18 [SEP] \n[row 23]: Common stock held in treasury | $(4,594) [SEP] \n[row 24]: Additional paid-in capital | $19,245 [SEP] \n[row 25]: Retained earnings (accumulated deficit) | $4,784 [SEP] \n[row 26]: Accumulated other comprehensive loss | $(2,199) [SEP] \n[row 27]: Total stockholders\u2019 equity | $17,254 [SEP] \n[row 28]: Noncontrolling interest | $33 [SEP] \n[row 29]: Total equity | $17,287 [SEP] \n[row 30]: Total liabilities and equity | $138,805 [SEP]"]